Watch Ticker

Spero Therapeutics, Inc. Common Stock

Go to Spero Therapeutics, Inc. Common Stock Website

$1.56

(%)
Live
Previous Close

$1.56

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$84.2 million USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebi...

Community
  • 0 posts discussing
0

Watchers

0

Visitors

Recent News

CAMBRIDGE, Mass., May 16, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying and developing novel treatments for rare diseases and multi-drug resistant (MDR) bacterial infections, today announced that Sath Shukla, President and Chief Executive Officer of Spero Therapeutics, will participate in a fireside chat and be available for one-on-one meetings at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ, to take place on Monday, May 20, 2024, at the NASDAQ World Headquarters New York, NY. Details are as follows:

Related tickers: SPRO.

Read Full Article

CAMBRIDGE, Mass., May 15, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying and developing novel treatments for rare diseases and multi-drug resistant (MDR) bacterial infections, today announced financial and operational results for the quarter ended March 31, 2024.

Related tickers: SPRO.

Read Full Article
Trending Tickers
FLGC

XNAS

$1.23
(%)
IBIT

XNAS

$39.97
(%)
LASE

XNAS

$2.28
(%)
MGAM

XNAS

$0.02
(%)
MLGO

XNAS

$0.00
(%)